More Globe Newswire

View Older Stories View Newer Stories

Apr 28, 2025 07:00AM Biomed Valley Discoveries Announces First Patient Dosed in Phase 1/2 Combination Study of Ulixertinib with Ruxolitinib (Jakafi®) in Patients with Myelofibrosis
Apr 28, 2025 07:00AM Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award
Apr 28, 2025 07:00AM EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease
Apr 28, 2025 07:00AM Kandi Technologies Reports 2024 Financial Results
Apr 28, 2025 07:00AM Nayax to Showcase End-to-End Payment Ecosystem at The NAMA Show, May 7-9 in Las Vegas
Apr 28, 2025 07:00AM Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025
Apr 28, 2025 07:00AM Matador Technologies Inc. Announces Symbol Change and DTC Eligibility of its Common Shares
Apr 28, 2025 07:00AM Atana Expands Sales Team, Welcomes New Leaders to Drive Continued Growth
Apr 28, 2025 07:00AM Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025
Apr 28, 2025 07:00AM Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2025 on the Potential of its CDK2-directed Molecular Glue Degrader to Treat HR-posit
Apr 28, 2025 07:00AM Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
Apr 28, 2025 07:00AM Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting
Apr 28, 2025 07:00AM G2 Continues to Expand New Surface Gold Discovery and Provides Exploration Update
Apr 28, 2025 07:00AM Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Apr 28, 2025 07:00AM XORTX Announces Grant of European Patent
Apr 28, 2025 07:00AM Barrick Gold Corporation Plans to Change Name to BARRICK MINING CORPORATION
Apr 28, 2025 07:00AM Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
Apr 28, 2025 07:00AM Beamr to Participate in Upcoming Investor Conferences in May 2025
Apr 28, 2025 07:00AM ScottsMiracle-Gro CEO Reports Strong POS Unit Gains During CNBC Mad Money Appearance
Apr 28, 2025 07:00AM Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
Apr 28, 2025 07:00AM Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combine
Apr 28, 2025 07:00AM Globavend Receives Government Non-Dilutive Grant Funding Approval
Apr 28, 2025 07:00AM DecisionDx®-Melanoma Test Ordered More Than 200,000 Times for Patients Diagnosed with Cutaneous Melanoma
Apr 28, 2025 07:00AM Village Farms International Takes Top Honors at the 2025 Stevie® Awards
Apr 28, 2025 07:00AM Osisko Development Announces Optimized Feasibility Study for Permitted Cariboo Gold Project with C$943 Million After-Tax NPV5% and 22.1% IRR at US$2,400/oz Base Case Gold Price; at US$3,300/oz Spot Go
Apr 28, 2025 07:00AM Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients
Apr 28, 2025 07:00AM ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
Apr 28, 2025 07:00AM AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer
Apr 28, 2025 07:00AM Green Thumb to Open RISE Dispensary Ocala in Florida, its 104th Retail Location in the Nation, on April 29
Apr 28, 2025 07:00AM Benevity Appoints Industry’s First Chief Artificial Intelligence Officer
Apr 28, 2025 07:00AM Widmer Brothers Brewing Celebrates 40th Anniversary
Apr 28, 2025 07:00AM Prairie Operating Co. Begins Completion of the Opal Coalbank Pad, Acquired from Bayswater
Apr 28, 2025 07:00AM Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
Apr 28, 2025 07:00AM Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
Apr 28, 2025 07:00AM CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Year-End 2024, Q1-2025, No Effects from Tariffs
Apr 28, 2025 07:00AM Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025
Apr 28, 2025 07:00AM Aktsiaselts Infortar Investor Webinar introducing the results of the Q1 2025
Apr 28, 2025 07:00AM AccuStem Sciences, Inc. and EmeritusDX Announce Partnership to Commercialize MSC Test for Lung Cancer Screening
Apr 28, 2025 07:00AM Signify share repurchase period update
Apr 28, 2025 07:00AM Avacta Therapeutics Presents Preclinical and Translational Data from pre|CISION® Platform Candidates at 2025 AACR Annual Meeting
Apr 28, 2025 07:00AM Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
Apr 28, 2025 06:55AM Roper Technologies announces first quarter financial results
Apr 28, 2025 06:50AM Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
Apr 28, 2025 06:49AM Form 8.5 (EPT/RI) - Inspired Plc
Apr 28, 2025 06:47AM Form 8.5 (EPT/RI) - Anexo Group Plc
Apr 28, 2025 06:45AM Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual Meeting
Apr 28, 2025 06:44AM TDC NET A/S – Publication of Prospectus Supplement
Apr 28, 2025 06:40AM Oma Savings Bank Plc to publish its January-March 2025 interim report on 5 May 2025
Apr 28, 2025 06:36AM FINGRID GROUP – MANAGEMENT’S REVIEW 1.1.−31.3.2025
Apr 28, 2025 06:30AM BYDFi Lists SIGN/USDT Trading Pair with $5,000 Prize Pool
View Newer Stories View Older Stories